NZ181683A - 1-alkyl-3-iminoalkyl-4-hydroxy-6-rhenyl-2-(ih)-pyridone derivatives and pharmaceutical compositions - Google Patents

1-alkyl-3-iminoalkyl-4-hydroxy-6-rhenyl-2-(ih)-pyridone derivatives and pharmaceutical compositions

Info

Publication number
NZ181683A
NZ181683A NZ181683A NZ18168376A NZ181683A NZ 181683 A NZ181683 A NZ 181683A NZ 181683 A NZ181683 A NZ 181683A NZ 18168376 A NZ18168376 A NZ 18168376A NZ 181683 A NZ181683 A NZ 181683A
Authority
NZ
New Zealand
Prior art keywords
rhenyl
iminoalkyl
hydroxy
alkyl
pharmaceutical compositions
Prior art date
Application number
NZ181683A
Other languages
English (en)
Inventor
J Nadelson
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of NZ181683A publication Critical patent/NZ181683A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/69Two or more oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/18Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Anesthesiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
NZ181683A 1975-08-06 1976-08-04 1-alkyl-3-iminoalkyl-4-hydroxy-6-rhenyl-2-(ih)-pyridone derivatives and pharmaceutical compositions NZ181683A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60232475A 1975-08-06 1975-08-06

Publications (1)

Publication Number Publication Date
NZ181683A true NZ181683A (en) 1979-01-11

Family

ID=24410893

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ181683A NZ181683A (en) 1975-08-06 1976-08-04 1-alkyl-3-iminoalkyl-4-hydroxy-6-rhenyl-2-(ih)-pyridone derivatives and pharmaceutical compositions

Country Status (16)

Country Link
AT (1) ATA579476A (US20080094685A1-20080424-C00004.png)
AU (1) AU507216B2 (US20080094685A1-20080424-C00004.png)
BE (1) BE844882A (US20080094685A1-20080424-C00004.png)
CA (1) CA1064935A (US20080094685A1-20080424-C00004.png)
CH (1) CH626077A5 (US20080094685A1-20080424-C00004.png)
DE (1) DE2633819A1 (US20080094685A1-20080424-C00004.png)
DK (1) DK342876A (US20080094685A1-20080424-C00004.png)
ES (1) ES450507A1 (US20080094685A1-20080424-C00004.png)
FI (1) FI762152A (US20080094685A1-20080424-C00004.png)
FR (2) FR2361886A1 (US20080094685A1-20080424-C00004.png)
GB (1) GB1563336A (US20080094685A1-20080424-C00004.png)
IE (1) IE43698B1 (US20080094685A1-20080424-C00004.png)
NO (1) NO762643L (US20080094685A1-20080424-C00004.png)
NZ (1) NZ181683A (US20080094685A1-20080424-C00004.png)
PH (1) PH11844A (US20080094685A1-20080424-C00004.png)
ZA (1) ZA764732B (US20080094685A1-20080424-C00004.png)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2801190A1 (de) * 1977-01-19 1978-07-20 Sandoz Ag 3-(alpha-iminobenzyl)-4-hydroxy-2(1h)- pyridon-derivat

Also Published As

Publication number Publication date
AU507216B2 (en) 1980-02-07
FI762152A (US20080094685A1-20080424-C00004.png) 1977-02-07
ATA579476A (de) 1981-06-15
BE844882A (fr) 1977-02-04
ZA764732B (en) 1978-03-29
CH626077A5 (en) 1981-10-30
CA1064935A (en) 1979-10-23
IE43698B1 (en) 1981-05-06
AU1661276A (en) 1978-02-09
DK342876A (da) 1977-02-07
FR2360585A1 (fr) 1978-03-03
ES450507A1 (es) 1977-12-16
FR2360585B1 (US20080094685A1-20080424-C00004.png) 1980-02-15
DE2633819A1 (de) 1977-02-24
NO762643L (US20080094685A1-20080424-C00004.png) 1977-02-08
PH11844A (en) 1978-07-21
GB1563336A (en) 1980-03-26
IE43698L (en) 1977-02-06
FR2361886A1 (fr) 1978-03-17

Similar Documents

Publication Publication Date Title
NZ181726A (en) Pyrrolidine derivatives and pharmaceutical compositions
NZ181444A (en) -phenyl benzylidene derivatives and pharmaceutical compositions
NZ180529A (en) Erythromyc-9-yl-amine derivatives and pharmaceutical compositions
IL51074A0 (en) Isoquinolinium derivatives their preparation and pharmaceutical compositions containing them
NZ182837A (en) Glucosamine derivatives and pharmaceutical compositions
IL48990A (en) 687-benzomorphan derivatives methods for their preparation and pharmaceutical composition comprising them
GB1520447A (en) Benzisoquinoline derivatives and pharmaceutical uses thereof
NZ182759A (en) Pyrimidine derivatives and pharmaceutical compositions
NZ181959A (en) Pyrimidine derivatives and pharmaceutical compositions
NZ182665A (en) Amine derivatives and pharmaceutical compositions
ZA763917B (en) Pharmaceutical compositions and compounds
IL50869A (en) Heterocyclylthio-ethylimidazole derivatives,their preparation and pharmaceutical compositions containing them
NZ181009A (en) Heteroaryl derivatives and pharmaceutical compositions
GB1518041A (en) Oxadiazolinone derivatives and compositions containing them
GB1537880A (en) 1-triarylalkyl-4-phenyl-4-piperidine-methanols and derivatives and pharmaceutical compositions containing them
NZ180379A (en) Benzophenone derivatives and pharmaceutical composition
NZ181503A (en) Substituted diphenyls-ulphides and pharmaceutical compositions
NZ182591A (en) 14-substituted-daunorubicins and pharmaceutical compositions
NZ182161A (en) Alkoxy-pyridine-carobxamide derivatives and pharmaceutical compositions
NZ181972A (en) N-aryl-n-(4-piperidyl)-arylacetamide derivatives and pharmaceutical compositions
NZ181864A (en) Noroxymorphones and pharmaceutical compositions
NZ182581A (en) -amino-ketones and pharmaceutical compositions
IL48453A0 (en) Novel quinuclidine derivatives and pharmaceutical compositions containing them
IL50335A (en) Diphenylalkylpolyamine derivatives,their preparation and pharmaceutical compositions containing them
PH13912A (en) Substituted benzamide derivatives and pharmaceutical compositions thereof